Brain Stimulation for Speech Improvement
Trial Summary
What is the purpose of this trial?
The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with plasticity not only in motor areas of the brain but in auditory and somatosensory regions as well.
Will I have to stop taking my current medications?
The trial excludes participants who are taking psychoactive medications, so you may need to stop taking those if you are currently on them. The protocol does not specify about other types of medications.
What data supports the effectiveness of the treatment Adaptation in the clinical trial Brain Stimulation for Speech Improvement?
Research shows that non-invasive brain stimulation, like transcranial direct current stimulation (tDCS), can enhance speech adaptation by improving how the brain integrates auditory feedback into speech motor plans. Additionally, tDCS has been effective in improving speech and language outcomes in conditions like post-stroke aphasia, suggesting its potential benefit in speech improvement.12345
Is brain stimulation for speech improvement generally safe for humans?
How does the treatment Adaptation differ from other treatments for speech improvement?
The treatment Adaptation uses noninvasive brain stimulation, specifically transcranial direct current stimulation (tDCS), to enhance speech motor learning by increasing the brain's ability to integrate auditory feedback into speech motor plans. This approach is unique because it directly targets the brain's speech motor cortex to improve speech production, unlike traditional speech therapies that may not involve direct brain stimulation.110111213
Research Team
David Ostry
Principal Investigator
Yale University
Eligibility Criteria
This trial is for right-handed individuals who speak fluent English, have normal hearing, and no speech or reading disabilities. It's not suitable for those with metal implants, neurostimulators, cochlear implants, a history of neurological disorders or concussion, on psychoactive medications, pregnant women, or anyone with certain heart devices.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Learning and Adaptation
Participants perform learning tasks with altered auditory feedback and undergo cTBS or fMRI to assess speech motor learning and retention.
Retention Assessment
Retention of learning is assessed 24 hours after initial learning tasks.
Follow-up
Participants are monitored for safety and effectiveness after the retention assessment.
Treatment Details
Interventions
- Adaptation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator